Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|December 6, 2003
Ropivacaine combined with various anti-arrhythmic drugs results in mild alterations in myocardial contractility in pigsCécile Barel, Majda Belkhiria, Bernard Bui-Xuan, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|November 26, 2008
Heart lesions associated with anabolic steroid abuse: comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbitsLaurent Fanton, Dalila Belhani, Fanny Vaillant, et al.
Regulatory Toxicology and Pharmacology : RTP|February 27, 2018
Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiativeJacques Descotes, Linda Allais, Philippe Ancian, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|June 6, 2012
Involvement of neuroleptic drugs in selenium deficiency and sudden death of cardiac origin: study and human post-mortem examinationLamia Hamdan, Muriel Bost, Guy Chazot, et al.
Journal of Analytical Toxicology|June 7, 2014
Analytical findings of an acute intoxication after inhalation of methoxetamineLaurent Imbert, Alexandra Boucher, Gilles Delhome, et al.
Journal of Anesthesia|October 31, 2006
The effects of ropivacaine at clinically relevant doses on myocardial ischemia in pigsPanayota Tsibiribi, Cécile Bui-Xuan, Bernard Bui-Xuan, et al.
Fundamental & Clinical Pharmacology|November 21, 2015
Safety profile of etifoxine: A French pharmacovigilance surveyJudith Cottin, Aurore Gouraud, Marie-Josèphe Jean-Pastor, et al.
European Journal of Endocrinology|March 11, 2025
Additive effects of ALXN2420, a GH receptor antagonist, and octreotide on IGF1 suppression in vivoGuillaume Ravel, Xavier Gaume, Corentin Berardet, et al.
Journal of Immunotoxicology|October 30, 2008
Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactionsJames L Weaver, Joan M Chapdelaine, Jacques Descotes, et al.
Pageof 8